Bought today Fiendish for exactly the same chart pattern you indicated.Rode it last time from 30c to $4, will need to go to $50 this time to beat it.Here's hoping
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%